Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

Biomarker Based Diagnosis of Alzheimer's Disease: Ready or Not, Here…

University of Utah Neurology

E. Mcdade

Cognitive Disorders

ZINCARE

M. Mataa

Approach to Cognitive Impairment in Adults

ZINCARE

M. Mataa

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

Embracing Aging: Helping Our Loved Ones, Helping Ourselves

Pacific Neuroscience Institute

S. Kaiser, A. Effinger

Updates in Dementia

2023 Conference Coverage

P. Tipton

AAIC 2024 Insights: Effects of Gut Microbiota Dysbiosis on Cognitive…

AAIC 2024 Insights Hub

Y. (Laura) Zhang

Alzheimer's: Clinical Pearls

Lawrence Robbins

New & Emerging Treatments in Alzheimer's Disease

University of Miami

E. Crocco

Neuropsychological Assessment in Dementia Diagnosis

Northwestern Medicine Neurology and Neurosurgery

S. Weintraub

Preventing Cognitive Decline with Lithium

Psychiatry Redefined

J. Greenblatt

An Update on Alzheimer's Disease: New Strategies Across the Disease …

Miller Medical Communications

P. Tariot

The Illusion of Progress: Lecanemab in Alzheimer's Disease

Alberto Espay

Aducanumab: What Neurologists Should Know - Clinical Impact, Indicat…

Northwestern Medicine Neurology and Neurosurgery

I. Grant

A New Era for Brain Health in Primary Care: New Drugs and Diagnostics

University of Kansas Medical Center

J. M. Burns

AAIC 2024 Insights: Potential of Targeting the Alpha-1 Adrenergic Re…

AAIC 2024 Insights Hub

S. G. Pattanashetty

Demystifying Dementia: Differentiating the Most Common Dementias

University of Kansas Medical Center

R. Townley